Mary Grace Rutland Joins PetVivo Holdings, Inc. as the Mid-Atlantic Business Development Manager
April 25 2023 - 8:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company")
an emerging biomedical device company focused on the
commercialization of innovative medical devices and therapeutics
for companion animals and animal athletes is pleased to announce
that Mary Grace Rutland has accepted a position with the Company as
its new Business Development Manager for the Mid-Atlantic Region of
the United States.
"We are incredibly excited to add Mary Grace to
our sales and distribution team,” said John Lai, Chief Executive
Officer of PetVivo Holdings, Inc. “The experience Mary Grace brings
to PetVivo is extraordinarily valuable to our efforts in
introducing our innovative product Spryng™ with OsteoCushion™
technology to veterinarians throughout the Mid-Atlantic states as
well as the entire United States”
Mary Grace Rutland (MG) brings to PetVivo 24
years of animal health sales and management experience. Her love of
horses took her to the University of Kentucky where she earned a
degree in equine science. During her career, Mary Grace has held
positions such as senior equine territory for Fort Dodge Animal
Health, veterinary field sales manager for Neogen Corporation, and
digital imaging specialist for Cuattro. To further her companion
animal industry experience, Mary Grace sold in-house lab analyzers
for Heska Corporation and most recently was a practice growth
consultant for Antech Diagnostics.
“I am incredibly excited to have the opportunity
to join the PetVivo sales and marketing team. It is a pleasure to
be part of a team that possesses vast experience in the development
and commercialization of life changing veterinary medical devices,”
said Ms. Rutland. “I truly believe Spryng with OsteoCushion
Technology has the ability to improve the medical outcomes of
animals suffering from lameness and other joint related
afflictions, such as osteoarthritis, thereby enhancing the lives of
animals and their owners.”
For more information about PetVivo Holdings,
Inc. and its innovative product, Spryng, please contact
info1@petvivo.com or visit https://petvivo.com/ and
https://sprynghealth.com/.
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG, a
veterinarian-administered, intraarticular injection for the
treatment of lameness and other joint related afflictions,
including osteoarthritis, in dogs and horses, is currently
available for commercial sale to veterinarians.
CONTACT:John Lai, CEOPetVivo Holdings,
Inc.Email: info1@petvivo.com(952) 405-6216
Forward-Looking commercial
Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements,
including the potential listing of the Company’s common stock on
Nasdaq, are based on information currently available the Company
and its current plans or expectations and are subject to a number
of uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jun 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024